SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-17-011326
Filing Date
2017-03-09
Accepted
2017-03-09 20:27:08
Documents
2
Period of Report
2017-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1682
2 EXHIBIT 24.1 POWER OF ATTORNEY poa_maetzel.htm EX-24.1 7048
  Complete submission text file 0001140361-17-011326.txt   10432
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address
Maetzel Andreas (Reporting) CIK: 0001576103 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36830 | Film No.: 17679977